EUCTR2006-005916-29-DE进行中（未招募）不适用
IFEROS – Influence of intravenous iron therapeutics on oxidative stress in hemodialysis patients - IFEROS
Westpfalz-Klinikum GmbH0 个研究点开始时间: 2007年6月5日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •stable hemodialysis patients at least three months on HD
- •age > 18 years
- •adequate hemodialysis with kt/v > 1,3
- •adequate iron stores with Serum-Ferritin >100 µg/dl and TSAT >20% or hypochrome erythrocytes < 10%
- •CRP < 30 mg/l
- •Hemoglobin >10 g/dl
- •stable on erythropoeitin: erythropoetin-dose 50 – 150 IU/kg/Woche and no change of erythropoeitin-dose > 30% in the last 8 weeks
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •·clinical signs of relevant inflammation or CRP > 30 mg/l
- •Hemoglobin < 10 g/dl or Hemoglobin >13g/dl
- •Serum-Ferritin <100 µg/dl or Serum-Ferritin > 800 µg/dl
- •TSAT > 50%
- •weekly iron substitition > 100 mg
- •hematologic systemic disease
- •immunsuppressive or cytostatic therapy
- •therapy with vitamin C, vitamin E or Acetylcystein
研究者
相似试验
进行中（未招募）
1 期
Impact of Iron Deficiency treatment with intravenous ferric carboxymaltose in patients with Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease and Iron DeficiencyMedDRA version: 20.0Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2017-003659-52-PTAntónio Robalo Nunes70
招募中
Unknown
Effect of intravenous iron supplementation on the level of hemoglobin in staged bilateral knee arthroplastyDiseases of the musculoskeletal system and connective tissueKCT0008823Chonnam National University Hospital Hwasun Hospital120
招募中
不适用
Effect of intravenous iron supplementation on the level of hemoglobin in revision hip and knee arthroplastyDiseases of the musculo-skeletal system and connective tissueKCT0005832Chonnam National University Hospital Hwasun Hospital120
尚未招募
2 期
To evaluate the improvement in exercise capacity, renal function, and cardiac parameters of participants with chronic kidney disease (CKD), heart failure, and iron deficiency after administering an interventional agent like intravenous iron.CTRI/2024/06/068710Shrinath Mashale
终止
3 期
The role of intravenous iron for patients with anaemia around the time of surgeryACTRN12611000387921yell McEwin Hospital136